| HOME >> BIOLOGY >> TECHNOLOGY |
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 78
16a. FRANCE 79
Market Analysis 79
Table 54: French Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 79
Table 55: French Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 80
Table 56: French 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 81
Table 57: French Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 82
Table 58: French Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 83
Table 59: French 11-
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |